Found 598 matching trials
Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) PHASE2 This trial has two parts. The purpose of the first part of the trial is to ...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma PHASE4 The aim of this study is to identify and/or validate biomarkers and imaging...
Show More Learn More & Join Trial
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow PHASE2 The goal of this clinical research study is to learn if sunitinib malate (S...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer PHASE2 The R0 resection rate in neoadjuvant chemotherapy for advanced ovarian canc...
Show More Location
Anhui Cancer Hospital
Learn More & Join Trial
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas PHASE2 The purpose of this study is to determine the clinical response rate (compl...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib N/A Retrospective correlation of clinical outcomes data with mutational status ...
Show More Learn More & Join Trial
Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics) N/A Information on the prevalence of advanced/metastatic renal cell carcinoma a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) PHASE2 This is a multicenter, Phase II, randomized, controlled, open label trial d...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) PHASE3 The main purpose of this study is to compare the objective response rate (O...
Show More Location
Alaska Urological
Learn More & Join Trial
Safety And Efficacy Study Of Sunitinib Malate As First-Line Systemic Therapy In Chinese Patients With Metastatic Renal Cell Carcinoma PHASE4 To investigate safety and efficacy of single agent sunitinib malate as firs...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial